Skip to content
  • Diet & Nutrition
  • Lifestyle & Wellbeing
  • News & Research
  • Treatment & Management
  • Patient Narratives
  • Glycaemic Index
  • Carbohydrate Counting
Quest Diabetes
Quest Diabetes
  • Diet & Nutrition
  • Lifestyle & Wellbeing
  • News & Research
  • Treatment & Management
  • Patient Narratives
  • Glycaemic Index
  • Carbohydrate Counting
Quest Diabetes
  • Treatment & Management

Menstrual cycle influences blood sugar levels more than previously understood, particularly in women with insulin resistance

New research highlights how hormonal shifts during the menstrual cycle can impact blood sugar regulation, especially in women with prediabetes, diabetes, or PCOS, prompting calls for cycle-aware monitoring. For many women, the days before a period bring a familiar mix…

  • apxadmin
  • August 10, 2026
  • News & Research

Real-world study suggests tirzepatide may outperform dulaglutide in treating HFpEF, but randomised trials are still needed

A large observational study indicates tirzepatide could offer superior outcomes over dulaglutide for patients with heart failure with preserved ejection fraction, sparking interest in further clinical trials. A large real-world study has found tirzepatide was associated with better outcomes than…

  • apxadmin
  • August 10, 2026
  • News & Research

UK becomes first in Europe to approve oral GLP-1 weight-loss medication for adults with obesity and type 2 diabetes

The UK has approved orforglipron, a new once-daily oral medication for weight management and type 2 diabetes, marking a first in Europe. The drug offers a convenient alternative to existing treatments and is subject to NHS evaluation before wider availability.…

  • apxadmin
  • August 10, 2026
  • Treatment & Management

First GLP-1 tablet for weight management approved in the UK disrupts obesity treatment options

Scotland-based health regulators have authorised orforglipron, a first-of-its-kind daily GLP-1 tablet, promising new options for adults with obesity and type 2 diabetes in the UK, subject to further NHS evaluation. Scotland-based health regulators have authorised a new daily weight-loss tablet…

  • apxadmin
  • August 10, 2026
  • Carbohydrate Counting

Understanding blood sugar responses: moderation and meal composition matter more than eliminating carbs

New insights highlight that managing blood sugar levels involves focusing on portion sizes and meal composition, rather than banning all sugars or starches, with experts emphasizing moderation and understanding different carbohydrate types. For people watching blood sugar, the issue is…

  • apxadmin
  • August 10, 2026
  • News & Research

Medtech industry faces reshaping as tariffs, inflation, and geopolitical tensions accelerate supply chain disruptions

Rising tariffs, inflation, and geopolitical tensions are forcing the medical technology sector to re-evaluate production and distribution models, particularly for diabetes devices, amid increasing industry resilience efforts. GlobalData Healthcare says tariffs, inflation and shifting geopolitical tensions are placing fresh strain…

  • apxadmin
  • August 10, 2026
  • News & Research

Quercetin’s potential in metabolic health faces hurdles despite promising mechanisms

While laboratory studies highlight quercetin’s multi-faceted influence on insulin pathways, inflammation, and gut health, clinical evidence remains inconsistent, underscoring challenges in translating its promise into effective treatments. Quercetin has emerged as one of the more closely watched plant compounds in…

  • apxadmin
  • August 10, 2026
  • News & Research

Study reinforces link between gum disease and increased risk of type 2 diabetes

A comprehensive review of over 300,000 individuals across 16 countries underscores the strong association between severe gum disease and future diabetes risk, highlighting the importance of integrating dental and medical care. A recent systematic review has added weight to the…

  • apxadmin
  • August 10, 2026
  • Diet & Nutrition

Reinventing ratatouille: versatile, diabetes-friendly vegetable stew gains modern twists

A timeless Provençal vegetable dish is being adapted into a flexible, health-conscious meal scheme, offering new varieties that prioritise flavour, fibre, and protein for those managing diabetes. Ratatouille, the Provençal vegetable stew, makes an easy lunchtime option for people looking…

  • apxadmin
  • August 10, 2026
  • Glycaemic Index

The deceptive marketing behind the “Glucose Reset Ritual” and its imitators

Repeated rebrandings and aggressive sales tactics characterise the “Glucose Reset Ritual” scams, which exploit authoritative appearances and false endorsements to deceive consumers into buying ineffective blood-sugar supplements with potentially harmful consequences. The “Glucose Reset Ritual” is less a single product…

  • apxadmin
  • August 10, 2026
Prev
1 … 174 175 176 177 178 179 180 … 199
Next

Search

No results

Posts

GLP-1 receptor agonists: revolutionising weight management with appetite control and metabolic benefits

August 12, 2026

New clinical guideline emphasises routine assessment and management of diabetes distress

September 23, 2026

Combining eggs, wholegrain toast, and peanut butter offers a balanced breakfast for blood sugar stability

August 13, 2026

Yale study finds no clear advantage of GLP-1 drugs in helping type 2 diabetes patients stop insulin

September 3, 2026

Expert advice highlights the importance of personalised management in type 2 diabetes

August 25, 2026

Trending now

Lipid risk marker flags hidden kidney and nerve damage risk in type 2 diabetes
New guidelines help people with diabetes enjoy summer cookouts without guilt
Gestational diabetes alters early brain response to food cues during pregnancy
Personal glucose pattern analyser offers targeted insights for diabetes management

Copyright © 2026 - QuestDiabetes.com

Disclaimer | Terms & Conditions | Privacy Policy